iNova Pharmaceuticals: Competitive Edge through Carbon Intelligence

PRODUCT IMPLEMENTED Corporate Carbon Footprinting (CCF) Product Carbon Footprinting (PCF) Transition Planning Extended Producer Responsibility (EPR) Reporting HQ Downtown Core, Singapore INDUSTRY Pharmaceuticals COMPANY SIZE Operations across 14 countries 500-1000 employees KEY RESULTS Audit-Ready Carbon Baseline : iNova Pharmaceuticals achieved a full Scope 1, 2, and 3 emissions measurement for FY’23, building a credible foundation for climate disclosures and year-on-year performance tracking. Product-Level Insights : Leveraged Terrascope’s AI-powered platform to enable targeted decarbonizati